Invasive Versus Non-invasive Assessment of Blood Pressure in Hypertensive Disorders of Pregnancy
Hypertension in Pregnancy
About this trial
This is an interventional diagnostic trial for Hypertension in Pregnancy focused on measuring invasive blood pressure, non-invasive blood pressure
Eligibility Criteria
Inclusion Criteria:
All Pregnant women diagnosed to have hypertensive disorders of pregnancy (chronic HTN, gestational HTN, pre-eclampsia or eclampsia) after control of hypertension using anti-hypertensive drugs.
Exclusion Criteria:
- Patients with previous cardiac diseases.
- Chronic kidney disease (CKD) which is defined as kidney damage or glomerular filtration rate (GFR) <60 mL/min/1.73 m2 for 3 months or more, irrespective of cause.
- Any disease requiring the use of anti-inflammatory medication, any other endocrine disease such as hyperthyroidism.
- Conditions that prevent invasive blood pressure measurement (arterial cannulation) as severe bleeding disorders.
- Patients refusing to join the study.
- Any associated severe comorbidities have been excluded.
Sites / Locations
- Assiut University Hospitals
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
patients
control
pregnant female with hypertension admitted in ICUfor control of BP invasive assessment of BP by radial cannulation was compared against non-invasive assessment of BP by an automated oscillometric BP device (Mobil-O-Graph )
matched control females of the same age but not pregnant invasive compared to non-invasive measurement of BP by same technique